SCHEMBL48365

SCHEMBL48365

CC(C)(N)c1ccccc1C(C)(C)N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
TSHR P16473 1/20 0.43
TAAR1 Q96RJ0 2/20 0.42
SLC6A2 P23975 1/20 0.42
CA2 P00918 1/20 0.39
KCNN4 O15554 2/20 0.38
AKT1 P31749 1/20 0.34
AKT2 P31751 1/20 0.34
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
MAPK1 P28482 1/20 0.33
PDE2A O00408 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
KIF11 P52732 1/20 0.32
CYP2C19 P33261 1/20 0.32
POLB P06746 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30678520 1.00 ALDH1A1 (0.43) ALDH1A1TDP1TSHRTAAR1SLC6A2
SCHEMBL20439254 0.91 TDP1 (0.50) ALDH1A1TDP1TSHRTAAR1SLC6A2
SCHEMBL4500149 0.87 ALDH1A1 (0.45) ALDH1A1TDP1TSHRMAPTKMT2A
SCHEMBL20439246 0.87 ALDH1A1 (0.36) ALDH1A1TDP1TSHRTAAR1SLC6A2
SCHEMBL164361 0.83 TSHR (0.45) ALDH1A1TDP1TSHRTAAR1SLC6A2
SCHEMBL29581427 0.83 TSHR (0.45) ALDH1A1TDP1TSHRTAAR1SLC6A2
SCHEMBL4706664 0.83 CYP3A4 (0.45) ALDH1A1TDP1TSHRTAAR1SLC6A2
Hydrochloric Acid SCHEMBL23886258 0.81 TDP1 (0.44) ALDH1A1TDP1TSHRTAAR1SLC6A2
Water SCHEMBL93584 0.81 TSHR (0.43) ALDH1A1TDP1TSHRTAAR1SLC6A2
Bromide SCHEMBL21460045 0.81 TSHR (0.43) ALDH1A1TDP1TSHRTAAR1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067602-A1 METHOD FOR PREPARING ISOCYANATE COMPOUND Hanwha Solutions Corporation (KR) 2024-02-29 US claimed
US-20240067601-A1 METHOD FOR PREPARING ISOCYANATE COMPOUND Hanwha Solutions Corporation (KR) 2024-02-29 US claimed
EP-4276091-A1 METHOD FOR PREPARING ISOCYANATE COMPOUND Hanwha Solutions Corporation (KR) 2023-11-15 EP claimed
EP-4273121-A1 ISOCYANATE COMPOUND PREPARATION METHOD Hanwha Solutions Corporation (KR) 2023-11-08 EP claimed
EP-4273123-A1 METHOD FOR PREPARING ISOCYANATE COMPOUND Hanwha Solutions Corporation (KR) 2023-11-08 EP claimed
EP-4273122-A1 ISOCYANATE COMPOUND PREPARATION METHOD Hanwha Solutions Corporation (KR) 2023-11-08 EP claimed
US-7405257-B2 Polyurethane resin-based material for slush molding SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2008-07-29 US claimed
US-20060045996-A1 Polyurethane resin based slush molding material SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2006-03-02 US claimed
EP-1493763-A1 POLYURETHANE RESIN BASED SLUSH MOLDING MATERIAL SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2005-01-05 EP claimed
EP-3831806-B1 DIISOCYANATE COMPOSITION FOR OPTICAL LENS AND PREPARATION METHOD THEREOF SK PUCORE CO LTD (KR) 2024-07-10 EP disclosed
US-11987541-B2 Method of preparing diisocyanate composition SK PUCORE CO., LTD. (KR) 2024-05-21 US disclosed
US-11964931-B2 Method of preparing diisocyanate composition and optical lens SK PUCORE CO., LTD. (KR) 2024-04-23 US disclosed
US-20240101508-A1 METHOD FOR PREPARING ISOCYANATE COMPOUND Hanwha Solutions Corporation (KR) 2024-03-28 US disclosed
US-11932591-B2 Method of preparing diisocyanate composition and optical lens SKC CO., LTD. (KR) 2024-03-19 US disclosed
US-6136378-A Method of coating a substrate using curable compositions containing novel polyfunctional crosslinking agents CYTEC TECHNOLOGY CORP. (US) 2000-10-24 US disclosed
US-6028141-A Polyfunctional crosslinking agents and curable compositions containing the same CYTEC TECHNOLOGY CORP. (US) 2000-02-22 US disclosed
EP-0912522-A1 POLYFUNCTIONAL CROSSLINKING ACYLIMIDAZOLIDINONE DERIVATIVES Cytec Technology Corp. (US) 1999-05-06 EP disclosed
WO-1997049687-A1 POLYFUNCTIONAL CROSSLINKING ACYLIMIDAZOLIDINONE DERIVATIVES CYTEC TECHNOLOGY CORP. (US) 1997-12-31 WO disclosed
EP-0149765-B1 COATING COMPOSITIONS CONTAINING A KETIMINE AMERICAN CYANAMID COMPANY (US) 1990-03-28 EP disclosed
US-4791063-A REMOVAL OF CONTAMINANTS FROM BIOLOGICAL FLUIDS CUNO INCORPORATED (US) 1988-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11987541-B2 Method of preparing diisocyanate composition INCENP, CENPE, SMO ALDH1A1 3706/4885TDP1 2137/4885TSHR 3052/4885
US-11964931-B2 Method of preparing diisocyanate composition and optical lens CRYAA, GCG, UACA ALDH1A1 3583/4885TDP1 2075/4885TSHR 2756/4885
US-11932591-B2 Method of preparing diisocyanate composition and optical lens CRYAA, GCG, AGT ALDH1A1 3154/4885TDP1 1913/4885TSHR 3245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.